Contrave (naltrexone/bupropion) is a prescription drug used for weight loss and long-term weight management in certain adults. The drug is prescribed along with diet ...
Currax Pharmaceuticals is kicking off the new year with a new direct-to-consumer campaign for its weight loss medication Contrave. The “Cravings Don’t Own Me” campaign includes the company ...
Takeda and Orexigen have been given FDA clearance to market their obesity treatment Contrave – but sales of the drug will be curtailed by a long list of severe side-effect risks. Contrave ...
Considering that a couple of mitigating factors to the success of GLP-1s have been the affordability and access of the drugs, Currax is aiming to highlight Contrave’s $99-per-month price point.
Jan. 2, 2025 /PRNewswire/ -- Currax Pharmaceuticals LLC ("Currax"), a specialty biopharmaceutical company and manufacturer of the #1 branded oral weight loss medication brand CONTRAVE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results